Eva Jerning

1.2k citations

16 papers · 919 indexed · h-index 10

Impact in

Cellular and Molecular Neuroscience top 5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases

Papers in ⓘ

Cellular and Molecular Neuroscience 11
- Neurotransmitter Receptor Influence on Behavior 6
- Neuroscience and Neuropharmacology Research 5
- Neuropeptides and Animal Physiology 4
Pharmacology 4
- Treatment of Major Depression 2

Co-authors: Yafeng Xue (2 shared papers)Mats Ormö (2 shared papers)Stefan von Berg (2 shared papers)Ratan V. Bhat (2 shared papers)Sven Hellberg (2 shared papers)Yvonne Nilsson (2 shared papers)Håkan Hall (2 shared papers)Nina Mohell (9 shared papers)
Journals: Journal of Pharmacology and Experimental Therapeutics (3 papers)Journal of Medicinal Chemistry (2 papers)European Journal of Pharmacology (2 papers)Journal of Biological Chemistry (1 paper)Nuclear Medicine and Biology (1 paper)
Partner nations: Sweden Spain United Kingdom

In The Last Decade

Eva Jerning

16 papers receiving 895 citations

Peers

Countries citing papers authored by Eva Jerning

Since Specialization

Citations

This map shows the geographic impact of Eva Jerning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Jerning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Jerning more than expected).

Fields of papers citing papers by Eva Jerning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Jerning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Jerning. The network helps show where Eva Jerning may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Jerning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Jerning Line = papers co-authored together Eva Jerning links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418 Journal of Biological Chemistry ·Ratan V. Bhat, Yafeng Xue, Stefan von Berg, Sven Hellberg, Mats Ormö, Yvonne Nilsson, Ann‐Cathrin Radesäter, Eva Jerning, Per-Olof Markgren, Thomas Borgegård, Martin Nylöf, Alfredo Giménez-Cassina, Félix Hernández, José J. Lucas, Javier Díaz‐Nido, Jesús Ávila	2003	460
2	Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines Journal of Medicinal Chemistry ·Stefan von Berg, Margareta Bergh, Sven Hellberg, Katharina Högdin, Yvonne Lo-Alfredsson, Peter Söderman, Tatjana Weigelt, Mats Ormö, Yafeng Xue, Julie A. Tucker, Jan Neelissen, Eva Jerning, Yvonne Nilsson, Ratan V. Bhat	2012	121
3	The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine1A Receptor Antagonist, NAD-299 Journal of Pharmacology and Experimental Therapeutics ·L. E. B. Johansson, Daniel Sohn, Seth-Olof Thorberg, D M Jackson, Diana Kelder, Lars‐Gunnar Larsson, Lucy Rényi, Svante B. Ross, Carin Wallsten, Henrik Eriksson, Ping Hu, Eva Jerning, Nina Mohell, Anita Westlind‐Danielsson	1997	107
4	Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain Receptors Acta Pharmacologica et Toxicologica ·Håkan Hall, Maria Sällemark, Eva Jerning	1986	92
5	Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites European Journal of Pharmacology ·Åsa Malmberg, Eva Jerning, Nina Mohell	1996	26
6	Robalzotan (NAD‐299), a Novel Selective 5‐HT_1AReceptor Antagonist CNS Drug Reviews ·Svante B. Ross, Seth‐Olov Thorberg, Eva Jerning, Nina Mohell, Carina Stenfors, Carin Wallsten, I.Gagner Milchert, G. Öjteg	1999	26
7	Two selective 5-HT 1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis Psychopharmacology ·David M. Jackson, Carin Wallsten, Eva Jerning, Ping Hu, Aaron M. Deveney	1998	24
8	Synthesis of Novel 5-Substituted 3-Amino-3,4-dihydro-2H-1-benzopyran Derivatives and Their Interactions with the 5-HT_1A Receptor Journal of Medicinal Chemistry ·Eva Hammarberg, Gunnar Nordvall, Robert Leideborg, Martin Nylöf, Sverker Hanson, Lars Johansson, Seth‐Olov Thorberg, Bo‐Ragnar Tolf, Eva Jerning, Gun Torell Svantesson, Nina Mohell, Charlotte Ahlgren, Anita Westlind‐Danielsson, I. Csöregh, Rolf Johansson	2000	17
9	Receptor binding characteristics of []NAD-299, a new selective 5-HT1A receptor antagonist European Journal of Pharmacology ·Eva Jerning, Gun Torell Svantesson, Nina Mohell	1998	15
10	The Pharmacological Profile of (R)-3,4-Dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a Selective 5-Hydroxytryptamine1A Receptor Agonist Journal of Pharmacology and Experimental Therapeutics ·Lucy Rényi, J. L. Evenden, Christopher J. Fowler, Eva Jerning, Diana Kelder, Desmond M. Lake‐Bakaar, Lars‐Gunnar Larsson, Nina Mohell, Maria Sällemark, Svante B. Ross	2001	9
11	NAD-299 ANTAGONISES 5-HT-STIMULATED AND SPIPERONE-INHIBITED [³⁵S]GTPγS BINDING IN CLONED 5-HT_1ARECEPTORS Journal of Receptors and Signal Transduction ·Eva Jerning, Susanne Rosqvist, Nina Mohell	2002	7
12	In Vitro Receptor Binding Characteristics of the New Dopamine D₂Antagonist [¹²⁵I]NCO-298: Methodological Considerations of High Affinity Binding Journal of Receptors and Signal Transduction ·Eva Jerning, Åsa Malmberg, Nina Mohell	1995	5
13	Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676 Journal of Pharmacology and Experimental Therapeutics ·Katarina Varnäs, Anders Juréus, Peter Johnström, Charlotte Ahlgren, P.A. Schött, Magnus Schou, Susanne Gruber, Eva Jerning, Jonas Malmborg, Christer Halldin, Lovisa Afzelius, Lars Farde	2016	4
14	Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors Nuclear Medicine and Biology ·Håkan Hall, Christer Halldin, Eva Jerning, Marie K. Österlund, Lars Farde, Göran Sedvall	1997	4
15	Comparison of the protective ability of O and K immunity in mice after immunization withEscherichia coli Current Microbiology ·Staffan Ahlsted, Eva Jerning, B. Kaijser	1981	1
16	The effects of sub-chronic treatment with the selective 5-HT1A receptor antagonist robalzotan, 8-OH-DPAT and antidepressive drugs on 5-HT1A, 5-HT2A, DA D2 and β-adrenergic receptors European Neuropsychopharmacology ·Eva Jerning, Nina Mohell	1998	1

About Eva Jerning

Eva Jerning is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Microbiology, Molecular Biology and Computational Theory and Mathematics, having authored 16 papers that have together received 919 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (5 papers), Neuropeptides and Animal Physiology (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Computational Drug Discovery Methods (2 papers), Treatment of Major Depression (2 papers) and Neuroendocrine regulation and behavior (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (336 citations), Pharmacology (139 citations), Molecular Biology (552 citations), Biological Psychiatry (18 citations) and Computational Theory and Mathematics (95 citations). Eva Jerning has collaborated with scholars based in Sweden, Spain and United Kingdom. Frequent co-authors include Yafeng Xue, Mats Ormö, Stefan von Berg, Ratan V. Bhat, Sven Hellberg, Yvonne Nilsson, Håkan Hall, Nina Mohell, Alfredo Giménez-Cassina and José J. Lucas. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, European Journal of Pharmacology, Journal of Biological Chemistry and Nuclear Medicine and Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact